Profund Advisors’s Keros Therapeutics KROS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $152K | Sell |
11,421
-148
| -1% | -$1.98K | 0.01% | 939 |
|
|
2025
Q1 | $118K | Buy |
+11,569
| New | +$118K | 0.01% | 938 |
|
|
2024
Q4 | – | Sell |
-8,392
| Closed | -$487K | – | 1156 |
|
|
2024
Q3 | $487K | Sell |
8,392
-2,415
| -22% | -$140K | 0.02% | 545 |
|
|
2024
Q2 | $494K | Sell |
10,807
-7,854
| -42% | -$359K | 0.02% | 500 |
|
|
2024
Q1 | $1.24M | Buy |
18,661
+7,814
| +72% | +$517K | 0.05% | 303 |
|
|
2023
Q4 | $431K | Buy |
10,847
+826
| +8% | +$32.8K | 0.02% | 592 |
|
|
2023
Q3 | $319K | Sell |
10,021
-2,914
| -23% | -$92.9K | 0.02% | 641 |
|
|
2023
Q2 | $520K | Buy |
12,935
+1,091
| +9% | +$43.8K | 0.03% | 501 |
|
|
2023
Q1 | $506K | Buy |
+11,844
| New | +$506K | 0.03% | 498 |
|